Krauss, A H <br/><br/>
Evidence for human thromboxane receptor heterogeneity using a novel series of 9,11-cyclic carbonate derivatives of prostaglandin F2 alpha.  [electronic resource] 

 -  British journal of pharmacology  Mar 1996 
 - 1171-80 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0007-1188 
<br/><br/><label>Standard No.: </label>10.1111/j.1476-5381.1996.tb16712.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid<br/>Animals<br/>Blood Platelets--drug effects<br/>Bridged Bicyclo Compounds, Heterocyclic<br/>Dinoprost--pharmacology<br/>Dose-Response Relationship, Drug<br/>Fatty Acids, Unsaturated<br/>Humans<br/>Hydrazines--pharmacology<br/>In Vitro Techniques<br/>Muscle Contraction<br/>Muscle, Smooth--drug effects<br/>Platelet Aggregation<br/>Prostaglandin Endoperoxides, Synthetic--pharmacology<br/>Prostaglandins F, Synthetic--pharmacology<br/>Receptors, Thromboxane--drug effects<br/>Thromboxane A2--analogs & derivatives<br/>Vasoconstrictor Agents--pharmacology